News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,741 Results
Type
Article (87567)
Company Profile (827)
Press Release (775327)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233114)
Career Advice (4140)
Deals (39817)
Drug Delivery (141)
Drug Development (91293)
Employer Resources (203)
FDA (18303)
Job Trends (17407)
News (397522)
Policy (39933)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (133)
Alliances (56980)
ALS (147)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (271)
Approvals (18345)
Artificial intelligence (525)
Autoimmune disease (111)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (534)
Cancer (4245)
Cardiovascular disease (379)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (717)
Cervical cancer (33)
Clinical research (75966)
Collaboration (1465)
Company closure (4)
Compensation (985)
Complete response letters (64)
COVID-19 (2966)
CRISPR (87)
C-suite (634)
Cystic fibrosis (142)
Data (5132)
Decentralized trials (2)
Denatured (65)
Depression (116)
Diabetes (472)
Diagnostics (7119)
Digital health (39)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (250)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99537)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133726)
Executive appointments (1000)
FDA (20921)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (18)
Funding (1314)
Gene editing (185)
Generative AI (52)
Gene therapy (576)
GLP-1 (1050)
Government (5398)
Grass and pollen (8)
Guidances (375)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (264)
Immuno-oncology (22)
Indications (61)
Infectious disease (3221)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17933)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (644)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (13)
Lung cancer (601)
Lymphoma (290)
Machine learning (33)
Management (66)
Manufacturing (678)
MASH (153)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22806)
Metabolic disorders (1222)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (240)
Neuropsychiatric disorders (64)
Neuroscience (2785)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (587)
Opinion (317)
Ovarian cancer (147)
Pain (173)
Pancreatic cancer (183)
Parkinson's disease (248)
Partnered (32)
Patents (435)
Patient recruitment (346)
Peanut (57)
People (66387)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23434)
Phase II (32962)
Phase III (24860)
Pipeline (3101)
Policy (307)
Postmarket research (3554)
Preclinical (10593)
Press Release (72)
Prostate cancer (208)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (719)
Real estate (7424)
Recruiting (79)
Regulatory (28181)
Reports (65)
Research institute (2700)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (78)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1071)
Venture capital (69)
Weight loss (414)
Women's health (64)
Worklife (21)
Date
Today (323)
Last 7 days (1268)
Last 30 days (3640)
Last 365 days (33703)
2025 (29277)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51106)
Australia (8983)
California (10143)
Canada (2974)
China (967)
Colorado (423)
Connecticut (449)
Delaware (290)
Europe (117504)
Florida (1480)
Georgia (328)
Hawaii (3)
Idaho (68)
Illinois (835)
India (56)
Indiana (494)
Iowa (20)
Japan (341)
Kansas (127)
Kentucky (39)
Louisiana (27)
Maine (80)
Maryland (1342)
Massachusetts (7559)
Michigan (322)
Minnesota (595)
Mississippi (4)
Missouri (127)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (81)
New Jersey (2794)
New Mexico (32)
New York (2706)
North Carolina (1463)
North Dakota (10)
Northern California (4707)
Ohio (312)
Oklahoma (22)
Oregon (51)
Pennsylvania (2080)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3867)
Tennessee (155)
Texas (1572)
United States (37052)
Utah (302)
Virginia (258)
Washington D.C. (85)
Washington State (856)
West Virginia (4)
Wisconsin (105)
Wyoming (2)
There are 863,741 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rapid zalunfiban treatment at 1st point of medical contact lowered risk of more severe heart damage in combination with other serious heart-attack complications
November 11, 2025
·
5 min read
Press Releases
NEURELIS TO PARTICIPATE IN SOFIE’S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND® RESORT
November 11, 2025
·
7 min read
Press Releases
Novo Nordisk’s Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
November 11, 2025
·
11 min read
Press Releases
DS3610 Enters Clinical Development in Patients with Advanced Solid Tumors as First STING Agonist ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo
November 11, 2025
·
3 min read
Press Releases
AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB)
November 11, 2025
·
3 min read
Press Releases
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
November 11, 2025
·
6 min read
Press Releases
Insilico and Lilly Enter a Research & Licensing Collaboration to Advance AI-Driven Drug Discovery
November 11, 2025
·
2 min read
Press Releases
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
November 11, 2025
·
19 min read
Press Releases
Organon Reports Results for the Third Quarter Ended September 30, 2025
November 11, 2025
·
21 min read
Press Releases
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances
November 11, 2025
·
7 min read
1 of 86,375
Next
